Search

Kevin R Rupprecht

from Gurnee, IL
Age ~69

Kevin Rupprecht Phones & Addresses

  • 6947 Bentley Dr, Gurnee, IL 60031 (847) 855-9173
  • Los Angeles, CA
  • Grayslake, IL
  • Liverpool, NY
  • 6947 Bentley Dr, Gurnee, IL 60031 (847) 366-8265

Work

Company: M&p biologics Apr 2016 Position: Vice president of research and development

Education

School / High School: University of Notre Dame

Skills

Program Management • Drug Development • Team Leadership • Microbiology • Cell Culture • Customer Service • Drug Discovery • Biotechnology • Biomarkers • Analytical Chemistry • Infectious Diseases • Immunology • Lifesciences • Validation • Biochemistry • Leadership • Cross Functional Team Leadership • Life Sciences • Strategic Planning • Gmp • Team Building • Fda • Medical Devices • Pharmaceutical Industry • Process Improvement • Management • Molecular Cloning • Business Process Improvement • Regulatory Affairs • U.s. Food and Drug Administration

Languages

English

Interests

Horses • Exercise • Home Improvement • Reading • Gourmet Cooking • Sports • Food • Home Decoration • Health • Cooking • Gardening • Electronics • Fitness • Music • Movies • Collecting • Kids • Medicine • Investing • Smoking

Emails

Industries

Medical Devices

Resumes

Resumes

Kevin Rupprecht Photo 1

Vice President Of Research And Development

View page
Location:
6947 Bentley Dr, Gurnee, IL 60031
Industry:
Medical Devices
Work:
M&P Biologics
Vice President of Research and Development

Abbott Sep 1985 - Apr 2016
Principal Research Scientist

Boy Scouts of America Sep 1985 - Apr 2016
Chartered Organization Representative, Troop 96 , Grayslake , Il
Education:
University of Notre Dame
Skills:
Program Management
Drug Development
Team Leadership
Microbiology
Cell Culture
Customer Service
Drug Discovery
Biotechnology
Biomarkers
Analytical Chemistry
Infectious Diseases
Immunology
Lifesciences
Validation
Biochemistry
Leadership
Cross Functional Team Leadership
Life Sciences
Strategic Planning
Gmp
Team Building
Fda
Medical Devices
Pharmaceutical Industry
Process Improvement
Management
Molecular Cloning
Business Process Improvement
Regulatory Affairs
U.s. Food and Drug Administration
Interests:
Horses
Exercise
Home Improvement
Reading
Gourmet Cooking
Sports
Food
Home Decoration
Health
Cooking
Gardening
Electronics
Fitness
Music
Movies
Collecting
Kids
Medicine
Investing
Smoking
Languages:
English

Publications

Us Patents

Hepatitis C Assay Utilizing Recombinant Antigens

View page
US Patent:
6593083, Jul 15, 2003
Filed:
Oct 17, 2000
Appl. No.:
09/690359
Inventors:
Sushil G. Devare - Northbrook IL, 60062
Suresh M. Desai - Libertyville IL, 60048
James M. Casey - Zion IL, 60099
Stephen H. Dailey - Vernon Hills IL, 60061
George J. Dawson - Libertyville IL, 60048
Robin A. Gutierrez - Gumee IL, 60031
Richard R. Lesniewski - Kenosha WI, 53142
James L. Stewart - Gumee IL, 60031
Kevin R. Rupprecht - Grayslake IL, 60030
International Classification:
C12Q 170
US Classification:
435 5, 435 71, 435 691, 435 713, 436536
Abstract:
Unique recombinant antigens representing distinct antigenic regions of the Hepatitis C Virus (HCV) genome which can be used as reagents for the detection of antibodies and antigen in body fluids from individuals exposed to HCV. The present invention also provides an assay for detecting the presence of an antibody to an HCV antigen in a sample by contacting the sample with the recombinant antigens. Preferred assay formats include a screening assay, a confirmatory assay, a competition or neutralization assay and an immunodot assay.

Neutrophil Gelatinase-Associated Lipocalin (Ngal) Protein Isoforms Enriched From Urine And Recombinant Chinese Hamster Ovary (Cho) Cells And Related Compositions, Antibodies, And Methods Of Enrichment, Analysis And Use

View page
US Patent:
8394606, Mar 12, 2013
Filed:
Nov 4, 2009
Appl. No.:
12/612061
Inventors:
Salman Ali - Hoffman Estates IL, US
Ryan M. Bonn - Kenosha WI, US
Frank C. Grenier - Libertyville IL, US
Tracey D. Rae - Glenview IL, US
Kevin R. Rupprecht - Gurnee IL, US
Hina N. Syed - Gurnee IL, US
Bailin Tu - Libertyville IL, US
Joan D. Tyner - Beach Park IL, US
Ryan F. Workman - Gurnee IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 1/14
US Classification:
435 691, 530424
Abstract:
A composition comprising neutrophil gelatinase-associated lipocalin (NGAL), which has been enriched from urine, has a molecular weight of about 24. 9 kDa to about 25. 9 kDa, and comprises a plurality of isoforms having isoelectric points (pIs) ranging from about 5. 9 to about 9. 1; a composition comprising NGAL, which has been enriched from recombinant Chinese hamster ovary (CHO) cells, has a molecular weight of about 25. 9 kDa to about 27. 9 kDa, and comprises a plurality of isoforms having pIs ranging from about 5. 6 to about 9. 1; a method of obtaining from urine a composition comprising a plurality of isoforms of NGAL, which method comprises enriching NGAL in urine without separating molecules based on charge; a method of obtaining from recombinant CHO cells a composition comprising a plurality of isoforms of NGAL, which method comprises enriching NGAL in a composition without separating molecules based on charge; and a method of analyzing NGAL isoforms enriched from urine or recombinant CHO cells comprising analyzing an enriched composition comprising NGAL isoforms by two-dimensional electrophoresis and Western blot.

Hepatitis C Assay Utilizing Recombinant Antigens

View page
US Patent:
61721891, Jan 9, 2001
Filed:
Jun 2, 1997
Appl. No.:
8/867611
Inventors:
Sushil G. Devare - Northbrook IL
Suresh M. Desai - Libertyville IL
James M. Casey - Zion IL
Stephen H. Dailey - Vernon Hills IL
George J. Dawson - Libertyville IL
Robin A. Gutierrez - Gurnee IL
Richard R. Lesniewski - Kenosha WI
James L. Stewart - Gurnee IL
Kevin R. Rupprecht - Grayslake IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 3804
A61K 3929
C07K 500
C12N 1501
US Classification:
530350
Abstract:
The present invention provides unique recombinant antigens representing distinct antigenic regions of the Hepatitis C Virus (HCV) genome which can be used as reagents for the detection of antibodies and antigen in body fluids from individuals exposed to HCV. The present invention also provides an assay for detecting the presence of an antibody to an HCV antigen in a sample by contacting the sample with the recombinant antigens. Preferred assay formats include a screening assay, a confirmatory assay, a competition or neutralization assay and an immunodot assay.
Kevin R Rupprecht from Gurnee, IL, age ~69 Get Report